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A Steric-Inhibition Model for Regulation
of Nucleotide Exchange
via the Dock180 Family of GEFs
and cell migration [1, 11]. These include both the cata-
lytic Docker domain that is located within the C-terminal
half of Dock180 and mediates nucleotide exchange on
Rac and an approximately 350 amino acid N-terminal
region that contains an SH3 domain. To better define
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inhibitory role. One possible mechanism for such SH3-
CDM (CED-5, Dock180, Myoblast city) familymembers mediated negative regulation is through binding to an-
have been recently identified as novel, evolutionarily other region (or other regions) of Dock180. Consistent
conserved guanine nucleotide exchange factors (GEFs) with this notion, the isolated SH3 domain (Dock1-83) or
for Rho-family GTPases [1–7]. They regulate multiple a slightly larger N-terminal fragment of Dock180 (Dock1-
processes, including embryonic development, cell mi-
161), coprecipitated with Dock (SH3) (Figure 1D and
gration, apoptotic-cell engulfment, tumor invasion,
data not shown). No interactionwas detectable between
and HIV-1 infection, in diverse model systems [4, 6,
the SH3 domain and the C-terminal proline-rich tail of8–16]. However, the mechanism(s) of regulation of
Dock180 (datanot shown).Whenother regionsofDock180CDMproteins has not been well understood. Here, our
were examined, the Dock1–161 fragment or the isolatedstudies on the prototype member Dock180 reveal a
SH3 domain readily bound the catalytic Docker domainsteric-inhibition model for regulating the Dock180
(Figure 1E, lane 4; Figure S2) Intriguingly, the SH3:family of GEFs. At basal state, the N-terminal SH3
Docker interaction does not seem to be a typicaldomain of Dock180 binds to the distant catalytic
SH3:PxxP binding; first, the W45A mutation within theDocker domain and negatively regulates the function
Dock180 SH3 domain, which abolished the domain’sof Dock180. Further studies revealed that the SH3:
binding to the PxxP motif of ELMO (Figure 1A), had noDocker interaction sterically blocks Rac access to the
effect on binding to the Docker domain (Figure 1E, laneDocker domain. Interestingly, ELMO binding to the
5); second, disrupting the single PxxP motif within theSH3 domain of Dock180 disrupted the SH3:Docker in-
Docker domaindid not affect theDocker:SH3 interactionteraction, facilitated Rac access to the Docker domain,
(Figure 1E, lane 6).and contributed to the GEF activity of the Dock180/
We then aligned the amino acid sequences from theELMO complex. Additional genetic rescue studies in
SH3 domains of CDM family members and comparedC. elegans suggested that the regulation of the
the consensus sequence with those from other SH3Docker-domain-mediated GEF activity by the SH3 do-
domains. We identified a conserved isoleucine residuemain and itsadjoining region isevolutionarily conserved.
(I32 of Dock180) within CDM family members; in mostThis steric-inhibition model may be a general mecha-
other SH3 domains, this residue is a lysine or glutamatenism for regulating multiple SH3-domain-containing
(Figure S3). Of note, this I32 residue resides in the ligandDock180 family members and may have implications
binding RT loop of the SH3 domains. Mutating this iso-for a variety of biological processes.
leucine residue to lysine (I32K) completely abrogated
the SH3:Docker interaction (Figure 1F, lane 3).Results and Discussion
We then tested whether the I32K mutation introduced
into the full-length Dock180 could functionallymimic theAn Inhibitory Interaction between the SH3
effects of deleting the SH3 domain. Remarkably, theand Docker Domains of Dock180
Previous studies showed a functional requirement for I32K mutation enhanced the activity of Dock180 in
at least two regions of Dock180 during phagocytosis phagocytosis in a manner similar to that of the SH3-
domain deletion (Figure 1C, lanes 7 and 8). When one
considers that the I32K mutation disrupted the SH3*Correspondence: ravi@virginia.edu
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Figure 1. An Inhibitory Interaction between SH3 and Docker Domains of Dock180
(A) The PxxP motif of ELMO binds to the SH3 domain of Dock180. GST-Dock1-161 or its W45A or I32K mutant version was transfected into
293T cells with either full-length ELMO-GFP or its PxxP-deletion mutant. After GST precipitation, the bound proteins were analyzed by
immunoblotting.
(B) The second interaction between Dock180 and ELMO and its disruption by G171E mutation. Flag-Dock180 or one of its mutants was
coexpressed with ELMO-GFP in 293T cells. Pre-cleared cell lysates were subject to anti-Flag precipitation. The bound proteins were analyzed
by immunoblotting. The ELMO1-629, which does not bind Dock180 [1], was used as a negative control.
(C) Phagocytosis assay. LR73 cells were transfected with wild-type Flag-Dock180 or one of its mutants together with either GFP (lanes 2–4)
or ELMO-GFP (lanes 6–8). The percentage of GFP-positive cells with engulfed particles was determined in a flow-cytometry-based engulfment
assay. The error bar represents the standard deviation.
(D) The SH3 domain of Dock180 binds to the SH3 domain-deleted Dock180 mutant. Flag-Dock (SH3) was coexpressed in 293T cells with
either GST or GST-Dock1-161. Cleared cell lysates were precipitated with anti-Flag and immunoblotted with the indicated antibodies.
(E) Interaction between the SH3 domain and the Docker domain of Dock180. Wild-type or mutant Flag-Docker domain and the indicated GST-
Dock1-161 or its W45A mutant were expressed in 293T cells, precipitated with anti-Flag antibody, and immunoblotted with the indicated
antibodies. The PP→AA mutation disrupted the single PxxP motif within the Docker domain.
(F) I32K mutation within the SH3 domain disrupts SH3 interaction with the Docker domain. Flag-Docker domain was cotransfected with GST-
Dock1-161 or its I32K mutant into 293T cells, precipitated with anti-Flag antibody, and immunoblotted with the indicated antibodies.
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binding to Docker, these data support the hypothesis disrupted its binding to both the Docker domain and
ELMO (Figures 1A and 1F). Collectively, these resultsthat the SH3:Docker interaction inhibits the functional
activity of Dock180. suggest that the binding of the PxxP motif of ELMO to
the SH3 domain of Dock180 can disrupt the SH3:Docker
interaction.SH3 Domain Blocks Rac Access
Consistent with the above observations, the bindingto the Docker Domain
of an ELMO fragment carrying the PxxP motif enhancedPrevious studies have shown that the binding of nucleo-
Rac binding to Dock180 (Figure 3C, lanes 2 and 5) totide-free Rac to the Docker domain is critical for Rac
an extent roughly equal to that observed with the Dockactivation by the Dock180/ELMO complex [1]. We hy-
(SH3) mutant (lanes 1 and 5). In contrast, coexpressionpothesized that the SH3domainmight exert its inhibitory
of ELMO (lanes 3 and 6) did not affect the binding ofeffect by blocking the access of Rac to the Docker
nucleotide-free Rac to the Dock (W45A) mutant. Of note,domain. Interestingly, the Dock (SH3) mutant associ-
here we used the W665A mutant of ELMO to avoid theated with nucleotide-free Rac significantly better than
ELMOPH-domain-mediatedcontribution toRacbindingwild-type Dock180 (Figure 2A). A similar result was seen
[18]. Similarly, ELMO interaction with Dock2 contributedwith another CDM family member, Dock2 [17], wherein
to enhanced Rac binding (Figure 2B). Collectively, thesedeletion of the N-terminal region resulted in better Rac
data suggested that the PxxP motif of ELMO binding tobinding (Figure 2B). Moreover, addition of nucleotide-
the SH3 domain of CDM proteins could relieve the SH3-free Rac inhibited the SH3 domain binding to the Docker
domain-mediated steric hindrance.domain (Figure 2C, lanes 2 and 3), suggesting that the
We next assessed the functional relevance of the Dock-SH3 domain and nucleotide-free Rac competitively bind
SH3:ELMO-PxxP interaction. In a fluorescence-based GEFtheDocker domain. Under the sameconditions, theGDP
assay, in which the association between Dock180 andboundRac, which does not bind theDocker domainwith
ELMO was primarily mediated via the SH3:PxxP interac-high affinity, did not reduce the SH3:Docker interaction
tion, the Dock180/ELMO complex showed 2-fold en-(Figure 2C, lanes 5 and 6).
hancement in GEF activity over Dock180 alone (FigureCompared with wild-type Dock180, the Dock (SH3)
3D, curves e and i). This enhancement was similar to thatmutant also showed increased basal Rac activation in
observed with wild-type Dock180 (curves d and g). Incells (increase of 1.6-fold  0.2-fold, p  0.05, n  3)
contrast, the SH3 mutant Dock (W45A) failed to syner-(Figure 2D). Deleting the SH3 domain fromDock180 also
gize with ELMO (W665A) in the in vitro GEF assay (datarendered it more active in the in vitro GEF assay (Figure
not shown). When examined in the Dock180/ELMO-S4). Recent studies suggest that wild-type Dock4 can
mediated, Rac-dependent Transwell migration of LR73promote Rac-GTP loading within cells when it is overex-
cells, the Dock (W45A) mutant failed to synergize withpressed (M.H. and V.Y., unpublished data). Also, com-
ELMO in promoting cell migration, whereas wild-typepared to wild-type Dock4, Dock4 in which the SH3 do-
Dock180 promoted migration (Figure 3E, lanes 5 and 6).main was deleted led to increased Rac-GTP loading in
At the level of the whole organism, we assessed thecells (increase of 1.7-fold  0.3-fold, Figure 2D). These
effect of disrupting the PxxP:SH3 interaction in C. elegansresults suggested that the SH3 domain of CDM proteins
gonadal distal-tip cell (DTC) migration. During C. eleganshas a negative regulatory role with regard to the Docker-
development, the distal-tip cell migrates in a stereotypi-domain-mediated Rac activation and that the removal
cal U-shaped pattern to define the shape of the adultof such inhibitionmay be required for the optimal activa-
hermaphrodite gonad. In worms with null mutations intion of this family of proteins.
ced-12 or ced-5, the DTC frequently mismigrates with
extra or wrong turns. This phenotype can be rescued,
ELMO Binding to the SH3 Domain Relieves respectively, by transgenic expression of wild-type ced-
the Inhibitory SH3:Docker Interaction 12 or ced-5. However, a ced-12 transgene with muta-
Compared with Dock180 alone, the Dock180/ELMO tions of its PxxP motif was less efficient in rescuing the
complex binds to the nucleotide-free Rac more effi- DTC-migration defects in CED-12 null animals (Table 1).
ciently and shows higher Rac-GEF activity [1, 10, 18]. Similarly, a ced-5 (SH3) mutant was also less efficient
Based on previous studies [1, 2, 10, 11, 19, 20], ELMO in rescue of DTC mismigration in CED-5 null worms
was considered as a prime candidate for disrupting the (Table 1). Taken together, these data suggested that the
SH3:Docker interaction via binding to the Dock180 SH3 Dock-SH3:ELMO-PxxP interaction is functionally rele-
domain (Figure 3A). Consistent with this model, coex- vant in vitro and in vivo and that a requirement for this
pression of ELMO reduced the amount of Dock1–161 interaction is evolutionarily conserved.
that coprecipitated with the Docker domain (Figure 3B,
lanes 1 and 3). In contrast, the Dock1–161:Docker inter-
action was not reduced by an ELMO mutant that lacks The Region Adjacent to the SH3 Domain Also
Affects the GEF Activity of Dock180the PxxP motif (lanes 1 and 5). Similarly, the binding of
the Docker domain to the Dock1–161 (W45A) mutant The regulation of the basal activity of Dock180 by its
N-terminal region was also supported by another set ofwas not reduced by coexpression of ELMO (lanes 2
and 4). The Dock180 SH3 domain did not appear to observations. InDrosophilaMyoblast city, a single point
mutation within the region adjacent to its SH3 domainsimultaneously bind the Docker domain and ELMO be-
cause no detectable ELMO coprecipitated with the SH3 (corresponding to G171E mutation in Dock180; Figure
S5) resulted in dorsal-closure and myoblast-fusion de-domain bound to the Docker domain (data not shown).
Furthermore, the I32K mutation within the SH3 domain fects comparable to those of Mbc null alleles [9]. Inter-
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Figure 2. SH3 Domain Blocks the Access of Rac to the Docker Domain
(A) Deletion of the SH3 domain promotes the binding of nucleotide-free Rac to Dock180. Flag-Dock180 or its SH3-deletion mutant was
transfected into 293T cells with either GST or GST-Rac. The total cell lysates were subjected to GST precipitation in the presence of 10 mM
EDTA and immunoblotted with the indicated antibodies.
(B) Deletion of the N-terminal region of Dock2 or association with ELMO enhances nucleotide-free Rac binding to Dock2. A Dock2 (N)
construct [17] or wild-type Dock2 with or without ELMO was expressed in 293 T cells, and lysates were precipitated with coexpressed GST-
Rac (in the presence of EDTA) and assessed for coprecipitation of Dock2 or its N mutant. It is notable that the Dock2 (N) construct was
poorly expressed in comparison to wild-type Dock2. After densitometry, the signals for Rac-associated Dock2 were normalized against protein
expression in the total lysates, and the signal intensity for wild-type Dock2 alone was arbitrarily set to 1.
(C) Nucleotide-free Rac competes with Dock1-161 in binding to the Docker domain. Flag-Docker was expressed and precipitated from
transfected 293T cells. Precipitates were then incubated with bacterially produced Dock1-161 or Rac (1 g of each) as indicated. Normalized
quantitation of the intensity of the GST-Dock1-161 bands is indicated below each band. The results are representative of two independent
experiments. LC indicates the light chain of antibody.
(D) SH3-domain-deleted Dock180 and Dock4 are more active in Rac activation within cells. 293T cells were cotransfected with Rac and wild-
type Dock180 or its SH3 mutant. The intracellular Rac-GTP level was assessed, in triplicates, by precipitation with GST-CRIB beads and
immunoblotting for Rac (upper panel). Rac-GTP levels were normalized against the expression level of Rac and Dock180 proteins (lower left
panel). Results from similar experiments comparing wild-type and SH3 versions of Dock4 were also presented (lower-right panel). The error
bars denote one standard deviation.
estingly, G171E mutation within Dock180 resulted in an ELMO (Figure 1B). These combined effects might ex-
plain the severe phenotypes associated with this muta-approximately 50% reduction in the basal in vitro GEF
activity (Figure 3D, curves d and e). This G171Emutation tion in Drosophila. When tested in CED-5-deficient
worms, the Dock (G171E) mutant was completely defec-also disrupted the second interaction of Dock180 with
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Figure 3. ELMO Relieves the SH3-Mediated Inhibition of Dock180
(A) Model figure depicting the binding of ELMO to the SH3 domain of Dock180. This binding disrupts the SH3:Docker interaction and allows
Rac better access to the Docker domain.
(B) Binding of the PxxPmotif of ELMO to the SH3domain of Dock180 disrupts the SH3:Docker interaction. Flag-Docker domainwas coexpressed
in 293T cells with wild-type or mutant GST-Dock1-161 in the presence or absence of ELMO-GFP. Cell lysates were subject to anti-Flag-
antibody precipitation, and the coprecipitation of Dock1-161 in the presence or absence of ELMO was assessed by immunoblotting. After
densitometry, the signal for GST-Dock1-161 in the precipitates was normalized against its expression level in the total cell lysates, and the
GST-Dock1-161 value was set at 1 for the purpose of comparison. The results are representative of three independent experiments.
(C) ELMO enhances the binding of nucleotide-free Rac to wild-type Dock180 but not its W45A mutant. Indicated Dock180 or its mutant was
expressed in 293T cells with ELMO532-727 (W665A)-GFP (denoted as ELMO*). Cell lysates were subject to precipitation with bacterially
produced GST-Rac in the presence of EDTA.
(D) In vitro GEF assay. Flag-Dock180 or its G171E mutant was expressed in 293T cells either alone or together with ELMO-GFP or its W665A
mutant as indicated. The proteins were precipitated with anti-Flag antibody and eluted with Flag peptide. The eluted proteins were quantitated
after anti-Flag blotting, and equal amounts of Dock180 protein were used in a mant-GDP fluorescence-based in vitro GEF assay. The observed
mant-GDP dissociation-rate constants (obs) were indicated.
(E) Transwell migration assay. Wild-type Dock180 or its W45A mutant was transfected into LR73 cells with ELMO (W665A)-GFP. The relative
cell migration of transfected cells through a Transwell was scored.
Current Biology
376
Table 1. The SH3 and Adjacent Regions of CED-5/Dock180 and the PxxP Motif of CED-12 Influence DTC Migration In Vivo
Genotype Mismigration (Percent) n
(A) Effect of SH3 Deletion of CED-5 or PxxP Mutation of CED-12 on DTC Migration
DTC Mismigration in ced-5- and ced-12 Null Worms Is Rescued by ced-5 and ced-12
Wild-type 0 204
ced-5(n1812) 35 314
ced-12(k149) 36 305
ced-5(n1812); opEx732 [Peft-3::ced-5(WT)] 5 173
ced-12(k149); opEx872 [Peft-3::ced-12(WT)::yfp] 9 302
Partial Rescue of Mismigration in ced-12 Null Worms by the PxxP Mutant of ced-12
ced-12(k149); opEx874 [Peft-3::ced-12(AxxA)::yfp] 18 305
ced-12(k149); opEx873 [Peft-3::ced-12(AxxA)::yfp] 21 302
Partial Rescue of Migration Defects in ced-5 Null Worms by ced-5(SH3)
ced-5(n1812); opEx723 [Peft-3::ced-5(SH3)] 22 305
ced-5(n1812); opEx725 [Peft-3::ced-5(SH3)] 23 326
ced-5(n1812); opEx726 [Peft-3::ced-5(SH3)] 24 315
(B) Effect of G171E Mutation of Dock180 on Rescuing DTC-Migration Defects in CED-5-Deficient Worms
Partial Rescue of DTC-Migration Defects in ced-5 Null Worms by Wild-Type Dock180
ced-5(n1812); opEx763 [Peft-3::Dock180(WT)] 24 310
No Rescue of DTC-Migration Defects in ced-5 Null Worms by Dock(G171E)
ced-5(n1812); opEx379 [Peft-3::Dock180(G171E)] 44 302
ced-5(n1812); opEx371 [Peft-3::Dock180(G171E)] 53 405
ced-5(n1812); opEx382 [Peft-3::Dock180(G171E)] 50 304
During C. elegans development, the distal-tip cell (DTC) migrates in a stereotypical U-shaped pattern to define the shape of the adult
hermaphrodite gonad (wild-type). In worms with null mutations in ced-5 or ced-12, the DTC frequently migrates incorrectly with extra or wrong
turns (mismigrated). The ced-5(n1812) mutant or the ced-12(k149) was made transgenic for the indicated constructs. The percentage of
gonadal arms with migration defects was scored in multiple independent transgenic lines for each construct. All lines were coinjected with
the Plim_7::GFP marker for visualizing the gonadal arms. All of the CED-5, Dock180 and CED-12 constructs were expressed under the Peft-3
promoter.
tive in rescuing the DTC-migration defect, and in fact it the regulation of GEF activity of several CDM family
members, and this model has implications for multipleenhanced the DTC mismigration (Table 1). Taken to-
gether, these data suggest that the SH3 domain and its biological processes.
adjoining region critically regulate the GEF activity of
Supplemental DataDock180 and that the ELMO binding to the N-terminal
Supplemental Experimental Procedures, three figures, and a tableregion of Dock180 may alleviate the inhibitory SH3:
are available with this article online at http://www.current-biology.
Docker interaction and fully activate Dock180. com/cgi/content/full/15/4/371/DC1/.
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